Literature DB >> 20007568

Long-term follow-up of survival in Hodgkin's lymphoma.

George P Canellos, Donna Niedzwiecki, Jeffrey L Johnson.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20007568     DOI: 10.1056/NEJMc0906731

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  9 in total

Review 1.  Appropriate surveillance for late complications in patients in remission from Hodgkin lymphoma.

Authors:  Deborah L Darrington; Julie M Vose
Journal:  Curr Hematol Malig Rep       Date:  2012-09       Impact factor: 3.952

2.  How can we better predict treatment outcomes in classical Hodgkin's lymphoma?

Authors:  Claudio Agostinelli
Journal:  Int J Hematol Oncol       Date:  2017-11-20

Review 3.  Advances in the treatment of Hodgkin lymphoma.

Authors:  Dennis A Eichenauer; Andreas Engert
Journal:  Int J Hematol       Date:  2012-10-11       Impact factor: 2.490

Review 4.  Optimisation of chemotherapy and radiotherapy for untreated Hodgkin lymphoma patients with respect to second malignant neoplasms, overall and progression-free survival: individual participant data analysis.

Authors:  Jeremy Franklin; Dennis A Eichenauer; Ingrid Becker; Ina Monsef; Andreas Engert
Journal:  Cochrane Database Syst Rev       Date:  2017-09-13

Review 5.  Hodgkin Lymphoma: Differences in Treatment Between Europe and the United States/North America: Evolving Trends in Protocol Therapy.

Authors:  Thomas J FitzGerald; Maryann Bishop-Jodoin
Journal:  Clin Med Insights Oncol       Date:  2018-01-31

6.  Clinical features and treatment outcomes of Hodgkin lymphoma: A retrospective review in a Malaysian tertiary hospital.

Authors:  Yang Liang Boo; Helen Siew Yean Ting; Diana Fui Sing Yap; See Guan Toh; Soo Min Lim
Journal:  Blood Res       Date:  2019-09-25

7.  High efficacy of PD-1 inhibitor after initial failure of PD-L1 inhibitor in Relapsed/Refractory classical Hodgkin Lymphoma.

Authors:  Xi Chen; Haiying Kong; Linxiang Luo; Shuiyun Han; Tao Lei; Haifeng Yu; Na Guo; Cong Li; Shuailing Peng; Xiaowu Dong; Haiyan Yang; Meijuan Wu
Journal:  BMC Cancer       Date:  2022-01-03       Impact factor: 4.430

8.  Treatment outcomes and relative dose intensity of chemotherapy in patients with advanced Hodgkin lymphoma.

Authors:  Samo Rožman; Barbara Jezeršek Novaković; Nina Ružić Gorenjec; Srdjan Novaković
Journal:  Oncol Lett       Date:  2022-07-19       Impact factor: 3.111

9.  Clinical features and treatment outcomes of Hodgkin's lymphoma in Hong Kong Chinese.

Authors:  Man Fai Law; Ting Ying Ng; Hay Nun Chan; Ho Kei Lai; Chung Yin Ha; Charlotte Leung; Celia Ng; Yiu Ming Yeung; Sze Fai Yip
Journal:  Arch Med Sci       Date:  2014-06-27       Impact factor: 3.318

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.